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Abstract
Background: With further expansion of the number of conditions for which newborn screening can be undertaken, it
is timely to consider the impact of positive screening results and the confirmatory testing period on the
families involved. This study was undertaken as part of a larger programme of work to evaluate the Expanded Newborn
Screening (ENBS) programme in the United Kingdom (UK). It was aimed to determine the views and experiences of
healthcare professionals (HCPs) and parents on communication and interaction during the period of confirmatory
testing following a positive screening result.
Methods: Semi-structured interviews were undertaken with parents of children who had received a positive
ENBS result and HCPs who had been involved with the diagnosis and support of parents. Ten parents and
11 healthcare professionals took part in the in-depth interviews. Questions considered the journey from the
positive screening result through confirmatory testing to a confirmed diagnosis and the communication and
interaction between the parents and HCPs that they had been experienced. Key themes were identified
through thematic analysis.
Results: The results point to a number of elements within the path through confirmatory testing that are
difficult for parents and could be further developed to improve the experience. These include the way in
which the results are communicated to parents, rapid turnaround of results, offering a consistent approach,
exploring interventions to support family relationships and reviewing the workload and scheduling implications for
healthcare professionals.
Conclusions: As technology enables newborn screening of a larger number of conditions, there is an increasing need
to consider and mediate the potentially negative effects on families. The findings from this study point to a number of
elements within the path through confirmatory testing that are difficult for parents and could be further developed to
benefit the family experience.
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Background
The advantages of newborn screening (NBS) in terms
of early detection and treatment of serious conditions
are well-documented [1–3]. Until recently in the UK
routine newborn screening (NBS) was undertaken for
five conditions Sickle cell disease, Cystic Fibrosis,
Congenital Hypothyroidism, Phenylketonuria and
Medium-Chain Acyl-CoA Dehydrogenase Deficiency
(MCADD) [4]. In 2012 Expanded newborn screening
(ENBS) for five additional inherited metabolic diseases
(IMDs) was introduced as a pilot programme for
Maple Syrup Urine Disease (MSUD), Homocystinuria
(pyridoxine unresponsive) (HCU), Isovaleric Acidaemia
(IVA), Glutaric Aciduria Type 1 (GA1) and Long
Chain Hydroxyl Acyl CoA Dehydrogenase Deficiency
(LCHADD) at six centres in England [4–6]. From
2015, the UK National Screening Committee adopted
screening for four of the five additional conditions
(HCU, MSUD, GA1 and IVA) within the UK NBS
programme.
With the expansion of screening programmes to
include additional rare conditions, there is a need to
further consider, and minimise the impact on families
where possible [7, 8]. Expanded screening will
increase the identifications of conditions (true posi-
tives), but also result in an increase in the number of
false positive results where an initial out of range
screening result for a condition is followed by
confirmatory testing that indicates the disorder is not
present [8–11]. This lower positive predictive value
associated with a screen positive test result is charac-
teristic of some of the newer candidate disorders.
Whether a condition is found to be present, the
period of confirmatory testing can cause significant
anxiety for the families concerned as they wait for
results [12–14]. Research has indicated an impact on
family relationships, parental depression and ongoing
relationships with health care professionals (HCPs)
[15, 16]. The communication and support provided
during the confirmatory testing period are thought to
mediate the impact on the family [9, 13, 17–20].
Guidelines exist to guide the communication of
screening results [16, 21, 22] but implementation is
believed to vary in practise and further exploration of
parental and clinician views is warranted. Existing
research on communication in this context has been
conducted mainly in the USA and findings cannot be
directly applied to the UK where screening is designed
as a community based activity with an emphasis on
integrated care during the maternity pathway [23].
The study described here was undertaken as part of a
larger programme of work to evaluate the ENBS pilot in
the UK. ENBS pilot studies have tended to report on the
performance of the service (e.g. screen-positive prevalence
and predictive value, screening uptake) [24–26] with
limited exploration of communication and the parental
and clinician experience during the pilot. Here it was
aimed specifically to determine the views and experiences
of healthcare professionals (HCPs) and parents on
communication and interaction during the period of
confirmatory testing following a positive screening result.
Methods
Semi-structured interviews were undertaken with
parents of children who had received a positive ENBS
result and HCPs who had been involved with the
diagnosis and support of parents during the pilot
period (July 2012–July 2013). The study was approved
by the National Research Ethics Service (East Midlands
committee, Northampton, UK). All participants gave
their written informed consent prior to participation
in the study.
Recruitment and participants
The ENBS program involved screening across six
centres in the UK: Sheffield Children’s NHS Foundation
Trust, Leeds, Great Ormond Street Hospital, Manchester
Children’s Hospital, Birmingham Children’s Hospital and
Guy’s and St Thomas’ NHS Foundation Trust. Inclusion
criteria for the HCP sample stated that Metabolic
Physicians, Specialist Metabolic Nurses, and Specialist
Metabolic Dieticians involved in the ENBS pilot with
experience of communicating screening results to parents
would be invited to take part. A key factor for inclusion
was availability for interview, as getting busy clinical staff
for interview was an issue, and therefore there was an
element of opportunity involved. Eleven semi-structured
interviews were conducted with six metabolic physicians,
two nurses and three dieticians. This represented at least
one member of staff from each of the six screening
centres.
The parental sample included mothers and fathers
who received a true or a false positive ENBS result and
were able to give informed consent. Parents under 16 or
unable to give informed consent were excluded. During
the ENBS pilot there were total of 30 screen positives
(12 false positives and 18 true positive). They were asked
by the NHS Trusts whether they would consent to being
contacted about related research. Seventeen provided
consent to be contacted about the study; nine of these
were successfully contacted by telephone and agreed to
take part. To improve recruitment, the sample was later
widened to include those who were screened for these
conditions while screening was extended and one
additional participant recruited.
Ten parents took part; two interviews were undertaken
as paired interviews with both the father and mother
present. Two participants were recruited through Great
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Ormond Street, one from Sheffield, one from Leeds and
six from Birmingham. The conditions for which they
screened positive, and time elapsed between the screen-
ing result and the interview are indicated in Table 1. The
parents and HCPs involved were not matched in this
study; whilst the screening centre for each parental
participant was recorded, the HCPs involved in the
process were not.
Eight participants’ children had a true positive screen.
Two were identified as false positive cases; however
further testing led to a diagnosis of a benign condition
in one case, and equivocal results for the other as
reported by the parents at the time of the interview.
Four out of the five ENBS conditions were represented.
The children ranged from being healthy, managed
through diet, to having been very sick at discrete episodes.
Procedure
The semi-structured interview schedules were developed
through consultation with the project team (see Additional
files 1 and 2 for interview schedules). For the HCPs,
questions probed experiences of giving screening results,
parental responses to the news, and their recommendations
regarding communication. The differences in approach
taken to parents suspected of having a true versus a false
positive screening result were explored. Questions for the
parents considered their journey from the positive screen-
ing result through confirmatory testing to a confirmed
diagnosis and the communication and interaction with
HCPs that they experienced. Whilst the approach offered
some structure, it was possible to discuss issues as they
were raised by participants.
The interviews were undertaken by three experi-
enced researchers from Coventry University who have
conducted many interviews within a healthcare con-
text. They were unknown to the participants. The
participants were briefed on the purpose of the
interview and the researchers motivation to improve
family experiences when the interviews were arranged.
The HCP interviews were either undertaken face to
face at the NHS Trust sites, or on the telephone to
suit the requirements of the participants. The
interviews lasted 30–60-min. The interviews with
parents lasted 20–60 min and took place in the
homes of the parents or over the telephone to suit
the participant. Two interviews involved the parents
being interviewed together. Typically a young child
was present too. One interview was undertaken in a
combination of Urdu and Punjabi, and another in
Arabic, these were translated during transcription.
Analysis
The interviews were recorded, transcribed verbatim and
analysed independently by two researchers using
thematic content analysis to identify patterns within the
data [27]. Transcripts were coded line by line to identify
relevant aspects of the data, once a comprehensive set of
codes had been identified; repeated patterns across the
data set were identified to generate themes. These
themes were then reviewed, refined and illustrative
quotations selected.
Results
HCP and parent viewpoints have been synthesised
together in identifying key themes and emerging recom-
mendations summarised in Table 2.
Pre-screening information
Parents recalled consenting to take part in the ENBS
pilot programme [6] but felt they had little or no
knowledge of the ENBS condition with which their child
received a positive screen:
“He’s got a condition that we’ve not heard of before”
(P1: L230).
Parents had little recollection of pre-screening
information and indicated there was a need for more
general awareness of the conditions. They reported
that they had not expected to hear back following the
‘heel-prick’ and so felt unprepared for the result.
HCPs agreed that in their experience, parents
typically had not heard of the ENBS conditions and
were unfamiliar with the available pre-screening
information.
Initial contact
The first contact between the parent and an HCP to relay
the screening result left a strong lasting memory with
parents. Contact was made by telephone either to arrange
a home visit by the midwife or a nurse, or to ask the
parents to go into the hospital (with variations per area).
Table 1 Summary of participant demographics
Gender of
participant
Age of child
at interview
Condition True (TP) or false
positive (FP) screen
Male 21 months GA1 TP
Female 24 months GA1 TP
Female 9 months GA1 TP
Female 23 months IVA FP –diagnosis of
benign condition
Female 17 months HCU FP –equivocal results
Female 24 months MSUD TP
Female
Male
24 month IVA TP
Male
Female
14 months HCU TP
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The anxiety and long term memory of this initial call was
recognised by both parents and HCPs:
“..the very first phone call that they receive, that
information of a positive and there could be
something, that is the one that remains with them,
how that has been dealt with, how it’s been
communicated, that is the important one”
(HCP5: L46–8).
“It just sends you into panic……It makes you feel really
sick doesn’t it (P7: L448–451).
Parents recommended that the initial phone call
needed to provide ‘the right amount of information’ but
the quantity and content was difficult to define:
“I think when they ring you up they should explain
like what is it, they should tell you straight on the
phone why, because why should you be worried and
getting stressed, crying because, or your baby might
die, or it might be serious..” (P3: L116–119).
“I would try and avoid if it was me. I would try and
avoid giving away too much detail until you’re in a
position sat talking to these people where you can
explain a lot more fully rather than just this horrible
tit-bit of information.” (HCP8 L466–469).
This initial contact was perceived to affect anxiety
during the first face to face meeting with the consultant
specialist. There was agreement between parents and
HCPs that further consideration of the best way to make
contact with parents would be beneficial.
In some regions a screening or metabolic nurse was
able to go out to the family with the midwife to relay the
news of the positive screening result providing a familiar
HCP and a subject specialist, but was not always
possible due to resource limitations. It was agreed that
direct contact between the HCP and family the same
day was important. The reported time between the
phone call and direct contact with the specialist team
varied from about 15 min to 2 days. Parents felt, where
there was a delay some contact was needed with a
knowledgeable professional:
“… I suppose if somebody had come round and sat
down with us to try and keep us a bit calmer cos to
have a few minute phone call and then put the phone
down and sent an email you think Jesus Christ this is
awful” (P2: L226–229).
First consultation
The initial consultation between the parents, the meta-
bolic specialist and their team was typically a long meet-
ing, lasting 1 to 4 h. Typically a multi-professional team
approach (including a registrar, a screening and or meta-
bolic nurse and dietician) was taken to facilitate parental
and HCP understanding.
HCPs indicated that they give core information about
the condition and testing process, and then tailor their
approach and further information to the family needs
and understanding. The conditions are rare, hard to
understand and usually unknown to the parents:
Table 2 Recommendations for improving communication
and interaction
A summary of emerging recommendations and areas for future research
Pre-screening
• Awareness raising of the ENBS conditions amongst parents, the public
and wider HCP community.
Initial contact
• Development of exemplar communication scripts for the first call to
parents to relay screening results and / or arrange an appointment;
co-design of content with parents and HCPs.
• Ensure direct contact between a specialist and the family the same
day the parents are notified of the positive screening result
• Ensure access to advice and support during the period spent waiting
for a meeting with a specialist.
• Development of information related to true and false positive results
to be received by parents at the point of an initial screening result
being relayed; co-design of content with parents and HCPs.
• Ensure the availability of a neutral translator for relaying the
information to parents whose first language is not English.
Waiting for a confirmatory diagnosis
• Rapid turnaround of confirmatory results, ensuring that accurate
timeframes are given to the parents.
• Ensure access to support systems during the waiting period.
• Provision of clear, actionable information in verbal, written and online
mobile formats that can be easily shared.
• Provide clear guidance and maternal support around breastfeeding.
• Encourage personal support from a friend or wider family especially if
there is only one parent available.
Long-term support
• Ensure availability and referral to psychological support where required
once a diagnosis is reached.
• Development of a toolkit that provides condition specific information
for non-specialist clinicians to provide support to families from the
screening test onwards.
• Development of an online self-management resource for parents that
provides condition specific information and support for parents from
screening through to ongoing condition management.
System support mechanisms
• Consider how a consistent approach and service can be offered to
support families and embed evidence-based guidelines whilst taking
into account local context and resources.
• Review the resource implications of screen positives and conditions
identified through screening, to make recommendations regarding
resource allocation.
• Consideration of adaptable workload models and scheduling to cater
for the management of screen positive cases whilst minimising the
impact on the HCPs involved.
Future research
• Explore factors affecting diagnostic acceptance and how these factors
can be affected by clinical interactions.
• Explore psychological interventions to support family relationships
whilst managing a child with a long-term condition.
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“..the conditions they’re not names that people are
familiar with. I had one parent say to me ‘You know if
you told me it was down-syndrome I could understand’,
so we then have the other problem of this huge strange
name that people can’t even pronounce, so I kind of
break it down to things, sizeable information bits that
they can comprehend and then tell them not to
bother with this huge name but that’s what it
means.” (P5: L113–8).
Some parents were reported by HCPs to take the news
badly find the news of the screening result very difficult,
or not take it in. In general, parents indicated that at this
time they had tended to focus on the future, the worst
case scenario, and the implications of the condition and
wanted an accurate assessment of the likely reality:
“I just wanted to know for my child what is going to
happen to her…“(P2:L160).
Parents recalled being given an indication of the likely
diagnosis at this stage:
“…they said the heel prick was really high so it’s more
than likely that he’s got it “(P3 L284–5).
“Within half an hour of speaking to us they had kind
of…they only told us that something might be horribly
wrong but also put our minds at rest by saying it’s odd
that you know they would have expected to see
symptoms” (P8: L58–60).
HCPS were asked if they adapted their style if they
suspected a diagnosis would be reached from the
positive screening result. The majority of the metabolic
consultants felt they would adapt their communication
style if the screening marker levels strongly indicated a
true or false positive to minimise parental anxiety:
“Now, normally you’ve got some inkling of which
direction this is going to be, so again, you should have
tried to prepare them for the result you think you’re
going to get. And you know, 90% of the time you’re
probably fairly accurate in that (P6: L152–4).
Some cases were considered easy to clarify (for example
premature or ill babies), and were managed in such a way
to avoid causing too much anxiety. More confidence in
the likely outcome evolved over the ENBS pilot.
Typically (as reported by parents and the HCPs)
both the mother and father were able to attend the
appointments, and sometimes an additional family
member too. HCPs believed that it was preferable for the
parent to have someone else present for emotional
support, to inform discussions about the parental history
for inherited conditions, and ensure the family has the
knowledge to manage the child. However, it was also
noted that it can be difficult if there are too many people
in the room (including HCPs, family and interpreters):
“my concern is getting the balance right between too
many people in the room because that can actually be
difficult sometimes, it’s a bit overwhelming for
parents...” (HCP8 L287–9).
The HCPs and parents agreed that the first face to face
contact and consultation with a specialist led to reassurance:
“So most parents will cry at the end of the clinic or
afterwards when they’re with the nurses or dieticians,
but actually they normally leave feeling much better
than they did when they came”.(HCP6 L85–7).
“Once we got to the hospital they were knowledgeable
and professional – just the wait and initial call not
good” (P7 L497).
However, it was recognised by a number of parents
that they were too anxious during the first consultation
to take in all of the information given:
“Yeah probably just you know all little charts and
things what does that mean and what’s this and genes
are missing here and I don’t know, I don’t know what
you’re talking about and at the time I can’t process
because I’m just worried and upset for my baby and
yeah it’s too much”. (P2 L175–8).
The HCPs indicated that they aim to strike a balance
between the reality of the situation, worrying the parents
unnecessarily, and setting them at ease and therefore try
to keep information simple and spread out over the day.
Waiting for a confirmatory diagnosis
The period of waiting for confirmatory results was re-
ported to vary between hours to a week depending on the
condition and treatment protocol. For some conditions
families will go home as a day case to await confirmatory
results. For others (e.g. LCHADD) children were admitted
to the ward. HCPs noted that this can be difficult for the
parents, but gives the clinicians the opportunity to spend
time with the family, explain the condition and help with
dietary management whilst monitoring the child.
HCPs felt that the nature of the symptoms (e.g. sleepi-
ness, vomiting) for some ENBS conditions can be hard
to assess in a newborn which can lead to parental
anxiety and trips to hospital during this period. Waiting
for confirmatory results was acknowledged as difficult
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by HCPs, but considered better managed when parents
are reassured and have the information they need.
Parents reported that waiting for confirmatory results
was stressful. They believed that the hospital had tried
to turn the result around as quickly as possible:
“..think they did it as quickly as they could so that was
quite reassuring cos it was ...you just want to know don’t
you so they were quite good like that so yeah they did it
as quickly as they could, I don’t think they could have
done much better than they did”. (P8 L479–482).
Whilst waiting, some parents focused on the screening
result being inaccurate, others assumed the worst case
scenario:
“And I was like wow you’ve pretty much confirmed
that she’s got it, but to say you know 99% but we have
to do another one to set it to stone to confirm it
properly… but then I kept holding on to that 1%
thinking there’s still that chance”.(P2: L185–187.
“No, cause when you’re finding out that your baby can
end up like a flower and not moving at all, have brain
damage and I don’t think anybody would be not
stressed.” (P3: L311–2).
Some parents needed to implement dietary changes dur-
ing the waiting period (condition dependent). The ability to
breastfeed and accurate dietetics information about this
was recalled as important to mothers. One mother reported
that the stress stopped her from being able to breastfeed.
Reaching a diagnosis
HCPs indicated that where possible the news of a
confirmatory diagnosis was given face to face, and
where given on the telephone, the parents were called
in to discuss. Some parents reported receiving results
by telephone and some through face to face appoint-
ment. The parental response to a diagnosis was
described by the HCPs as individual and variable but
often reported to be one of great upset:
“Without a doubt there’s just going to be floods of
tears, shock and everything” (HCP5: L399).
“…it is bad news you can’t pretend it’s not you know
for families, you’re telling them that their child has
a lifelong condition that requires management.”
(HCP3;L265–7).
There was less detail recalled by parents about the
relaying of the confirmatory diagnosis than the initial
call about the screening result:
“So we must have gone four times in the first year
but I think, I don’t know about getting the diagnosis.”
(P8; 209–10).
The conditions are complex, and parents felt it took
time to absorb the information that their child’s condition
was confirmed:
“It took a long time to absorb it and understand what
was wrong with her…It was very overwhelming, and
just like wow, and you know at first I thought oh my
gosh this is awful” (P2: L67–72),
HCPs reported parents asking questions about
treatment, how the child would be affected, how
often they would be seen; alongside concern about
the future quality of life. Only one parent reported in
the interview feeling that she was unprepared for the
reality of her child’s condition. The majority felt they
were given appropriate information and support and
felt reassured once treatment was underway.
HCPs report that they aimed to communicate that the
screening and confirmatory test result was a good day
(not a bad one) as the knowledge of the condition would
improve child health. They noted cases of parental denial
of the condition where the child is not visibly unwell; or
in other cases parents had prepared themselves for the
worst case scenario.
HCPs were asked about the parental response to a
false positive screening result. It was typically described
as relief. In the majority of cases the parents were
reported not to make contact again, but some had rung
for reassurance. The management of the conditions vary
and so may affect the impact of the false positive on the
family. HCP contact with these families is not main-
tained so an ongoing impact may not be evident, but it
was hoped that long term impact could be moderated
through the cases being well managed.
The parental sample included two families who had a
longer period of diagnostic uncertainty. The screening
had detected a raised metabolite but had not led to
diagnosis of a screened for condition. In one case a clear
diagnosis was still not available to the parents at the
time of the interview; in the other a mild variant of
further condition was diagnosed. In both cases the
parents were glad the issue has been identified through
ENBS, explored and the child monitored.
Longer term family impact
Parents’ longer term responses to the diagnosis (as de-
scribed at the time of the interview) varied:
“..but she’s not a normal child, she’s not normal. If she
was normal I wouldn’t worry as much” (P4: 180–1).
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“I am happy that my baby is now normal like other
children, Her food is different…..I am very happy, the
whole credit goes to the metabolic team “(P6 L244–6).
One mother explained the conflict between wanting to
protect her child versus the desire to treat her normally.
Another indicated that she found it hard to explain to
her family what was wrong with the child and why she
worries.
The parents felt that HCP support since diagnosis was
knowledgeable and well managed:
“P7: They seemed very knowledgeable….
P8: …I don’t think there was a single ‘oh I’ll have to
come back to you’ answer to any of our questions, I
think everything was just answered there and then,
like I say we were dealing with people that…..”
(P7 & 8: L284–289).
Family support had been important. The challenge of
managing frequent hospital trips alongside care of other
children and employment was highlighted. Some mothers
had taken over management of the child’s condition and
family relationships were affected:
“To be very frank, the biggest difference was on my
personal life. Because what a mum can do, a father
can’t do. I am to this day doing it for my baby. Other
family friends, have also been affected, I can’t get out
as much” (PT6: L209–11).
“.... cos I’m always stressed over her, like I do
everything for her and I run around her quite a lot
(PT4: L193-4)”.
Three of the mothers interviewed indicated that their
relationships had broken down and they linked the
demands of having a child living with a condition. The
diagnosis also raised questions for them around genetic
carriers within the wider family and the impact on future
children.
Information resources and support mechanisms
The approach to communication by clinicians was
protocol driven, but styles were recognised to vary.
HCPs felt that communication and interaction with
parents during the confirmatory testing period should be
honest and reassuring, and some felt it was importance
to demonstrate confidence. The importance of breaking
down information to meet parental needs and using an
interpreter for parents with limited English was
highlighted by HCPs and non-English speaking parents.
Standard ENBS information sheets, emergency letters,
and follow up information were used across the centres.
The ENBS pilot website provided condition specific
information as well as videos, and charity links etc.
Parents generally reported that they received clear and
well explained information that helped them explain the
condition to family members:
“yeah, we, you know what, early we had so much
information on that condition from them and even
from the website, so all we wanted, we did get the
information”. (PT1: L216–8).
Some HCPs recommended the website to deter
parents from finding factually incorrect information
online. Others waited to refer to the website until a con-
dition was confirmed or warned parents off the internet
due to the tendency to find ‘worst case scenario’ cases
on unapproved sites. The majority of parents indicated
that they had sought out information online.
The screening centres provided direct telephone num-
bers for support and advice from the specialist team.
The contact numbers were often used by parents once
diagnosis was confirmed, and sometimes whilst waiting
for confirmatory results:
“I felt reassured because as soon as there’s a problem
we’ve got a number for them to ring them straight
away you know, any questions or anything we’ve got a
direct number to them so”. (PT5 L180–20).
The value of support groups was explored. It was felt
to be of mixed value amongst HCPs depending on the
nature and attendees of the group. Caution was
expressed that larger support groups could lead parents
to be scared by different experiences. One mother
wanted support to manage the demands of the condi-
tion. An interest was expressed in informal 1:1 relation-
ships between families affected in a similar ways by the
same condition.
Impact of ENBS
Parents felt lucky that they had benefited from the pilot
programme and were grateful to have been provided the
opportunity for early treatment. Only one of the inter-
viewed parents found that the uncertainty around the
condition and its early treatment had led to mistrust in
the treatment and HCPs.
Parents felt that there is limited awareness of ENBS
conditions and a need for increased knowledge amongst
the public and doctors in local hospitals:
“Yeah and even my doctor, my doctors been a doctor
for 30 odd years and the doctor at our local hospital
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has been a doctor for 40 years and they’ve never heard
of it and I’m thinking I’ve now got to educate you guys
(PT2: L69-71).”
From the HCP perspective, ENBS has led to new
knowledge and earlier diagnosis. HCPs reported initially
relying on their experience with existing screened condi-
tions, but condition specific knowledge and approaches
developed over the pilot. The learning curve was recog-
nised for managing cases as well as communication with
the family.
HCPs were asked about the impact of ENBS on them-
selves. The stress and anxiety involved in screening was
noted by some HCPs both in terms of the emotional
management of families but also due to the workload
implications. A positive screen takes priority which can
be hard to manage alongside other work demands, given
the resources needed to reach a diagnosis.
“Even the positives are additional but people say it’s
not, but the thing is actually it’s hard to even talk
to the Managers and say it’s an ad-hoc thing,
whenever it comes positive I have to drop everything”
(HCP5: L:450).
For true positive screening outcomes, there is a
grieving process for the parents to be managed; as well
as the treatment plan and ongoing consultation.
Discussion
The expansion of screening to include additional
complex and rare conditions presents challenges in
terms of providing accessible information to parents,
and communicating results effectively through sensi-
tive and supportive interactions with HCPs. This
study explored parental and HCP experiences of the
UK ENBS pilot with a focus on the period of con-
firmatory testing following a positive screening result.
The views of the parents and HCPs tended to be in
alignment raising similar issues of concern.
Awareness of the ENBS conditions was reported to be
low amongst parents prior to receiving the screening
results. Given the careful design of the ENBS informa-
tion and consent model prior to the pilot [6], it is likely
that parents did receive information and were explained
the nature of the pilot. However, in line with previous
research they may not have fully attended to, or retained
the condition specific information provided [28, 29]. As
providing adequate information for rare and complex
conditions continues to be a challenge, it is argued that
co-design [30] of paper-based and online information
with parents may further enhance the accessibility of the
key messages. Broader awareness raising of ENBS condi-
tions amongst the public and wider HCP community
may also be useful to aid parental and wider family
understanding.
The first contact, often by telephone, with parents
following a positive screening result leads to anxiety and
lasting memories for parents whilst being acknowledged
as particularly difficult by HCPs. The content of the
information provided ahead of a face to face meeting
warrants further consideration, particularly in areas of
the country where there may be a delay before direct
contact with a specialist. Communication scripts co-
developed with parents and HCPs are suggested as a
possible means to guiding the first contact.
The rapid availability of reliable and accessible condi-
tion specific information as well as support from HCPs
and family is important. In line with the literature,
participants’ views suggested that early direct contact
between the specialist team and the family and contin-
ued support, is likely to affect the long-term impact on
the family [21, 31]. Parents clearly have a desire to seek
information online and the availability of credible,
reliable resources that reflect the early detection of
conditions and discourage parents from accessing nega-
tive images and case studies is important. Condition
specific information can be overwhelming and hard to
process at a time of high anxiety for parents, so content
should be simple, clear and actionable and where
possible tailored to individual needs. The presence of an
independent translator where required to ensure that
information can be processed and responded to by the
parent is an imperative.
The increase in positive screening results (both true
and false positives) through ENBS, places a new and
different workload on HCPs and the healthcare
system. There was variation evident during the pilot
due to local resources and circumstances that affected
parental experience. It is important to consider how a
consistent approach and service can be offered to
embed evidence-based guidelines and protocols whilst
taking into account local context and resources. An
assessment of the resource implications of the con-
firmatory testing period alongside adaptable workload
models and scheduling to cater for the management
of screen positive cases is needed to support the
HCPs involved.
HCPs drew attention to the need to rapidly develop
healthcare knowledge to manage early detection of
the ENBS conditions as well as to effectively commu-
nicate with and support families. The availability of
online toolkits to support clinical knowledge develop-
ment, and offer a self-management resource for
parents that provides condition specific information
and support from screening through to ongoing
condition management may be mechanisms to help
support cost-effective delivery.
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Study limitations and future research
The participant sample in this study was relatively
small due to the inclusion criteria and challenge of
recruitment. However, the interviews benefitted from
an in-depth reflection on experiences and the HCPs
interviewed could reflect on multiple cases that they
had been associated with. Within the parental sample,
participants’ children had been affected by different
conditions, treated at different centres and received
different diagnoses. Cases will have been managed
differently; however, it is argued that it is this
variability that is of interest.
The time elapsed between receipt of the screening
result and the interview means the data is reliant on
recollection. However, it also reflects the longer-term
view of the parents and the impact on them. It provides
a useful collection of views about the emotional
response to the experience, although it is accepted that
factual data about information provided e.g. time frames
form parents may not be accurate.
Men are under-represented in research of this nature.
Fathers would often be on paternity leave at the time of
receiving the screening result; but accessing men for the
interviews sometime later proved difficult. Given the
impact on family relationships and employability, their
continued involvement in screening research is particu-
larly important.
The study highlighted varying responses to the
diagnostic experience. Future research is needed into the
factors affecting diagnostic acceptance and the impact of
clinical interactions on the long-term family response to
managing the conditions. As understanding increases of
the impact of screening and managing a child’s IMD, it
would be valuable to explore psychological interventions
to guide parents bonding and maintaining family rela-
tionships to help families to address the daily challenges
they may face.
Conclusions
This study sought to understand and learn from partici-
pants’ experiences of an ENBS pilot in the UK. With
further expansion of the number of conditions for which
screening can be undertaken and the increased rate of
false positive results observed in some of the newly
included disorders, it is timely to consider how the
impact of positive screening results can be minimised.
Although there are studies exploring the impact of
receiving positive NBS results, many focus on quantify-
ing the impact rather than detailed exploration of
experiences.
This qualitative study of experiences has highlighted
elements within the path through confirmatory testing
that are difficult for parents and could be further devel-
oped to benefit the family experience. In particularly, the
findings recognise there is a need to further develop the
information given and the mechanisms by which parents
are communicated with and supported. Recommenda-
tions have been made to address some of the challenges
raised by participants in order to further minimise the
impact on families of positive screening results.
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